Navigation Links
Study locates cholesterol genes; finds surprises about good, bad cholesterol
Date:1/13/2008

ANN ARBOR, Mich.---An international study of 20,000 people found seven new genes that influence blood cholesterol levels, a major factor in heart disease, and confirmed 11 other genes previously thought to influence cholesterol.

The international study led by researchers from the University of Michigan School of Public Health set out to identify or confirm genetic variants that influence lipid levels, and secondly, to see if those variants were linked to the decreased or increased risk of heart disease. The findings will be published online in the journal Nature Genetics on Jan. 13.

The results may lead the medical community to rethink the role of HDL (good cholesterol) and LDL (bad cholesterol) in heart disease, said Goncalo Abecasis, associate professor in the U-M School of Public Health. Abecasis co-directed the study with Karen Mohlke, assistant professor of genetics at the University of North Carolina at Chapel Hill School of Medicine.

"It was surprising that while genetic variants that increase your bad cholesterol are also associated with increased risk of heart disease, we did not find that variants influencing your good cholesterol were associated with decreased risk of coronary artery disease. Perhaps that result will lead us to reexamine the roles of good and bad cholesterol in susceptibility to heart disease," Abecasis said.

Coronary artery disease, a condition where plaque accumulates on the walls of coronary arteries, is the most common type of heart disease and a leading cause of death in industrialized countries. The type and amount of cholesterol and other lipids in the bloodstream contribute to the risk of coronary artery disease, which can cause heart attack, stroke, angina and other heart conditions. Both genetic and environmental factors influence a person's cholesterol and blood lipid levels.

"Finding new gene regions associated with cholesterol levels may bring us one step closer
'/>"/>

Contact: Laura Bailey
baileylm@umich.edu
734-647-1848
University of Michigan
Source:Eurekalert

1

GOOD

Page: 1 2

Related biology news :

1. Study suggests genetic connection between short stature and arthritis
2. Radioactive understudy may aid medical imaging, drug development
3. Surprise -- cholesterol may actually pose benefits, study shows
4. Hybridization partially restores vision in cavefish, NYU study finds
5. Study of sugars on cell surface identifies key factor in flu infection
6. Human hormone blocker found to help prevent obesity and diabetes: study
7. UVa biomedical engineering study shows magnetic field can reduce swelling
8. First-ever study to link increased mortality specifically to carbon dioxide emissions
9. Jefferson scientists studying the effects of high-dose vitamin C on non-Hodgkin lymphoma patients
10. Study examines genetic defects linked to body abnormalities in patients with childhood cancer
11. Deep-sea species loss could lead to oceans collapse, study suggests

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/30/2009)..., New Orleans, LA Researchers from LSU Health Sc... Eunice Kennedy Shriver National Institute of Chil...hool of Public Health, Brigham and Women,s Hospita...first time that drinking more than 5 servings of s...ears to significantly elevate the risk of developi...
(Date:11/30/2009)..., Two so-called invasion proteins are crucial for...surface of human cells, which stimulates the host ...ptor molecules exert a different function, for exa...ng. The group,s results have now been published in...iology ". , Spoiled meat is one of the sources f...
(Date:11/30/2009)..., If you ever thought the stress of seeing your e...g youbad news: a new research report in the Decemb...iology ( http://www.jleukbio.org ) shows that you...m the same study might lead to entirely new treatm..., arthritis, and eczema under control. That,s beca...
Breaking Biology News(10 mins):Sugary cola drinks linked for first time to higher risk of gestational diabetes 2Sugary cola drinks linked for first time to higher risk of gestational diabetes 3It takes 2 to infect 2Seeing family for the holidays? Scientists discover how the stress might kill you 2UCR scientists manipulate ripples in graphene enabling strain based graphene electronics 13195 1UCR scientists manipulate ripples in graphene enabling strain based graphene electronics 13195 2UCR scientists manipulate ripples in graphene enabling strain based graphene electronics 13195 3Surgery remans an option for advanced lung cancer 52719 1Surgery remans an option for advanced lung cancer 52719 2Common allergy drug reduces obesity and diabetes in mice 9359 1Common allergy drug reduces obesity and diabetes in mice 9359 2Common allergy drug reduces obesity and diabetes in mice 9359 3Common allergy drug reduces obesity and diabetes in mice 9359 4
...rcent of women rely on their healthcare providers ...ercent said their doctor has talked to them about ...avirus (HPV) - according to a new survey released ...onals (ARHP). HPV is extremely common, affecting a...n their lifetime, in some cases staying dormant un...
...r manipulating macromolecules has been developed b...ana-Champaign. The technique uses double-stranded ...In previous DNA nanotechnology efforts, duplex DNA...ometrical objects in three dimensions. Instead of ...rchers are using DNA to control the folding and re...
...r manipulating macromolecules has been developed b...ana-Champaign. The technique uses double-stranded ...In previous DNA nanotechnology efforts, duplex DNA...ometrical objects in three dimensions. Instead of ...rchers are using DNA to control the folding and re...
Other Biology News:Survey reveals women and doctors aren't talking about HPV 2Survey reveals women and doctors aren't talking about HPV 3Health costs soar as 60 million Americans classed as obese 2UN successfully tests 'green' pesticide against locusts 2
(Date:11/30/2009)...RK, Nov. 30 The Michael... today announced $1.5 million in total awards to s...isease-modifying therapies for Parkinson,s disease...hes to Drug Discovery for Parkinson,s Disease pro...on, plc (NYSE: ELN ), a neuroscience-based biote...
(Date:11/30/2009)...STERDAM, November 30 Biopharmaceut...e first patients have been enrolled in its,multina...The study is,designed to show reduction in transpl...ng an allogeneic stem cell transplantation with a ... patients eligible for an allogeneic,stem cell tra...
(Date:11/30/2009)...LLE, Md., Nov. 30 Novava...mpleted enrollment in the Phase II clinical study ...ommended strains) VLP vaccine candidate in healthy...This randomized, double-blind, active-controlled s...unogenicity of two different doses (15 mcg and 60 ...
(Date:11/30/2009)...EATTLE, Nov. 30 Cell The...nced today that its new class of platinum-based an...rated a stronger anti-tumor potency and activity c...ounds as well as the ability to overcome cisplatin...e presented in a paper titled "Novel Bis-platinum ...
Breaking Biology Technology:The Michael J. Fox Foundation Announces $1.5 Million in Funding to Advance Development of Drug Targets for Disease-Modifying Parkinson's Disease Treatments 2The Michael J. Fox Foundation Announces $1.5 Million in Funding to Advance Development of Drug Targets for Disease-Modifying Parkinson's Disease Treatments 3Kiadis Pharma Announces Enrollment of First Patients in a Multinational Registration Study for ATIR(TM) 2NOVAVAX Completes Enrollment in Phase IIa Study of Seasonal Influenza Vaccine in Older Adults 2NOVAVAX Completes Enrollment in Phase IIa Study of Seasonal Influenza Vaccine in Older Adults 3NOVAVAX Completes Enrollment in Phase IIa Study of Seasonal Influenza Vaccine in Older Adults 4New Class of Platinum-Based Anti-Tumor Drugs, Bisplatinates, Demonstrates Potent Anti-Tumor Activity and Ability to Overcome Resistance to Currently Available Platinum-Based Agents 2New Class of Platinum-Based Anti-Tumor Drugs, Bisplatinates, Demonstrates Potent Anti-Tumor Activity and Ability to Overcome Resistance to Currently Available Platinum-Based Agents 3
...aGen to receive approximately $45 million in cash,...ne payments - - Provides updated financ...o be hosted today at 9:00 a.m. EDT -, BRANFORD, C... ), a clinical-stage biopharmaceutical company, an...linostat, a Phase I/II histone,deacetylase inhibit...
...LLE, Calif., April 21 Ortho Evra is an adhesive,t...release 150 mcg of,norelgestromin and 20 mcg of et... It is replaced once a week for three weeks, and n... was approved by the FDA in November,2001, and ove...pproval.,Ortho Evra continues to be marketed aggre...
... Million Net Revenues, $0.03 Net Loss Per Share, ...logies, Inc. (Nasdaq: VNUS ), a leading provider ...tment of venous disease, today announced its,finan... 2008., Net revenues for the first quarter of 200....6 million for the first quarter of 2007. As,expec...
Other Biology Technology:CuraGen Sells Ownership of Belinostat to TopoTarget A/S 2CuraGen Sells Ownership of Belinostat to TopoTarget A/S 3CuraGen Sells Ownership of Belinostat to TopoTarget A/S 4CuraGen Sells Ownership of Belinostat to TopoTarget A/S 5Ortho Evra Patch Makers Settling Cases 2VNUS Medical Technologies Reports First-Quarter 2008 Results: 21% growth in Net Revenues and 51% Growth in Unit Sales 2VNUS Medical Technologies Reports First-Quarter 2008 Results: 21% growth in Net Revenues and 51% Growth in Unit Sales 3VNUS Medical Technologies Reports First-Quarter 2008 Results: 21% growth in Net Revenues and 51% Growth in Unit Sales 4VNUS Medical Technologies Reports First-Quarter 2008 Results: 21% growth in Net Revenues and 51% Growth in Unit Sales 5VNUS Medical Technologies Reports First-Quarter 2008 Results: 21% growth in Net Revenues and 51% Growth in Unit Sales 6VNUS Medical Technologies Reports First-Quarter 2008 Results: 21% growth in Net Revenues and 51% Growth in Unit Sales 7
Goat Anti-Human SCP3 / SYCP3 Affinity Purified Polyclonal Antibody, Unconjugated from R&D Systems
Rabbit Anti-Human ADH5 Polyclonal Antibody, Unconjugated from Proteintech Group, Inc.
Mouse Anti-Human Rad1 Monoclonal Antibody, Unconjugated, Clone 33 from R&D Systems
Cytological Nuclear Counterstain Kit - DAPI/SYTOX Green/PI - 300 slides from Molecular Probes (Invitrogen)
Biology Products: